Relx Plc (NYSE:RELX) Shares Sold by Squarepoint Ops LLC

Squarepoint Ops LLC reduced its position in shares of Relx Plc (NYSE:RELX - Free Report) by 72.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,697 shares of the technology company's stock after selling 20,010 shares during the period. Squarepoint Ops LLC's holdings in Relx were worth $350,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. CENTRAL TRUST Co lifted its position in shares of Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock worth $26,000 after buying an additional 529 shares during the last quarter. Transce3nd LLC acquired a new stake in Relx during the 4th quarter worth $40,000. Sierra Ocean LLC purchased a new stake in Relx in the fourth quarter valued at $43,000. Brown Brothers Harriman & Co. lifted its position in Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after acquiring an additional 662 shares during the last quarter. Finally, Private Trust Co. NA boosted its stake in Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after acquiring an additional 199 shares in the last quarter. Institutional investors and hedge funds own 15.02% of the company's stock.

Relx Stock Performance

Shares of NYSE:RELX traded down $0.61 on Monday, reaching $53.08. The company's stock had a trading volume of 696,190 shares, compared to its average volume of 730,903. Relx Plc has a 52-week low of $43.45 and a 52-week high of $56.33. The stock has a market capitalization of $97.97 billion, a P/E ratio of 28.53, a PEG ratio of 2.73 and a beta of 0.84. The stock's 50-day moving average is $52.66 and its two-hundred day moving average is $49.78. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on RELX. Wall Street Zen cut Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Morgan Stanley reissued an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. Finally, The Goldman Sachs Group initiated coverage on shares of Relx in a research report on Wednesday, March 26th. They set a "buy" rating on the stock. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Relx currently has an average rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.